Kinnevik AB (publ)
- SEC CIK
- 0001766574
- Latest filing
- Nov 4, 2025
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed Apr 14, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 2
- −1 vs. Q4 2022
- Portfolio value
- $74.5M
- −$102.7M (−58.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 7,653,061 | $51.0M | 68.5% | 00.0% | Unchanged | History |
| Babylon Hldgs LtdG07031100 | CL A SHS | 4,617,340 | $23.5M | 31.5% | 00.0% | Unchanged | – |
Sold out since Q4 2022 (1)
Positions held at the end of Q4 2022 that are gone from this filing.